argenx is a global immunology company committed to improving the lives of people living with severe autoimmune diseases. Partnering with leading academic researchers through its Immunology Innovation Program (IIP), argenx is translating immunology breakthroughs into a world-class portfolio of novel antibody-based medicines.

If you are entrepreneurial and committed to making a difference for patients then argenx is for you.

As a global immunology biotech, we have opportunities spanning Europe, the United States, Canada and Japan.